Page 3 - Param Desai News Today

Cipla stock price jumped more than 3 per cent on Friday after reports that Blackstone is in talks to buy out the promoter stake in the company.Last week, Ciplahad clarified that the company is not aware of any event that requires disclosure ...

Cipla has clarified that the company is not aware of any event that requires disclosure under Listing Regulations."The Company will make appropriate disclosure in compliance with the Listing Regulations as and when any such requirement ...

"The Company will make appropriate disclosure in compliance with the Listing Regulations as and when any such requirement arises," the company said in a filing. The clarification came regarding reports that Cipla promoters are looking to sell a part stake in the promoter shareholding to private equity investors.

However, the company’s March quarter (Q4FY23) results are broadly in line with Street estimates. Analysts say stable margin last quarter, expected gains from Curatio integration and new product launches are reasons for optimism.

Torrent Pharmaceuticals (TRP IN) - Param Desai - Senior Research Analyst, Prabhudas Lilladher Pvt Ltd

Cipla stock slipped 3.98% to Rs 897.7 against the previous close of Rs 934.90 on BSE. The large cap share has lost 1.38 % in one year and fallen 13.34% since the beginning of this year.

Eris Lifesciences has been on an acquisition spree in a bid to diversify its offerings. The company recently bought nine dermatology brands from both Dr Reddy’s Laboratories and Glenmark Pharma.

A sharp focus on biosimilars has propelled low-profile Aurobindo Pharma to second place in the Indian pharma pecking order, where it has stayed despite the pandemic. The journey to No. 1, though, will be tougher - Issue Date: Sep 18, 2022

Fringe benefit? Ortho clinic stock rides Covid wave, surges 50% in a month SECTIONS Share Synopsis The company is currently valued at Rs 1,700 crore, much of which has come during the last one year, as the stock gained 155 per cent. In fact, in the last one month alone, the stock has climbed 50 per cent. Shutterstock.com Analysts believe the frenzy to acquire the company’s shares was largely due to expected earnings from home care and Covid-19 treatment as well as the ongoing vaccination driv...